Efficacy of Biologic Therapy in Moderate-to-Severe Psoriasis
Biologic therapy demonstrated 89% reduction in PASI score at week 16 compared to 12% with placebo. Quality of life improved...
Congress: AAD 2024
American Academy of Dermatology Annual Meeting 2024
Novel Topical JAK Inhibitor for Atopic Dermatitis Treatment
Topical JAK inhibitor achieved 58% IGA 0/1 response at week 8. Rapid itch relief within 24 hours in majority of...
Immunotherapy for Advanced Melanoma: 5-Year Survival Data
Five-year overall survival reached 52% with combination immunotherapy vs 34% with monotherapy. Durable responses observed.
Dupilumab Efficacy in Adolescent Atopic Dermatitis
Dupilumab achieved clear/almost clear skin in 42% of adolescents by week 16. Significant improvement in itch and quality of life.
Early Intervention in Vitiligo: Outcomes and Predictors
Early treatment within 6 months of onset achieved 75% repigmentation vs 28% for delayed treatment. Facial lesions responded best.
Laser Treatment for Recalcitrant Warts: Comparative Study
Pulsed dye laser achieved 78% complete clearance vs 41% with cryotherapy. Fewer treatments required with laser.
Oral Minoxidil for Female Pattern Hair Loss
Low-dose oral minoxidil increased hair density by 18% at 24 weeks. Patient satisfaction high with minimal side effects.
Rosacea Subtype-Specific Treatment Approaches
Tailored therapy based on rosacea subtype achieved 72% improvement vs 43% with standard approach. Combination therapy most effective.
AI-Assisted Melanoma Detection in Primary Care
AI algorithm sensitivity 94% for melanoma detection vs 78% for general practitioners. Specificity 89% vs 85%.
Systemic Therapy for Hidradenitis Suppurativa: Real-World Outcomes
Biologic therapy achieved 63% HiSCR response at 16 weeks in real-world setting. Quality of life improved significantly.